A citation-based method for searching scientific literature

Matthew B Young, Seth D Norrholm, Lara M Khoury, Tanja Jovanovic, Sheila A M Rauch, Collin M Reiff, Boadie W Dunlop, Barbara O Rothbaum, Leonard L Howell. Psychopharmacology (Berl) 2017
Times Cited: 40







List of co-cited articles
672 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.
Michael C Mithoefer, Mark T Wagner, Ann T Mithoefer, Lisa Jerome, Scott F Martin, Berra Yazar-Klosinski, Yvonne Michel, Timothy D Brewerton, Rick Doblin. J Psychopharmacol 2013
205
55

3,4-Methylenedioxymethamphetamine facilitates fear extinction learning.
M B Young, R Andero, K J Ressler, L L Howell. Transl Psychiatry 2015
49
52


3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.
Michael C Mithoefer, Ann T Mithoefer, Allison A Feduccia, Lisa Jerome, Mark Wagner, Joy Wymer, Julie Holland, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson,[...]. Lancet Psychiatry 2018
145
40



MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?
Allison A Feduccia, Michael C Mithoefer. Prog Neuropsychopharmacol Biol Psychiatry 2018
64
35

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
Michael C Mithoefer, Allison A Feduccia, Lisa Jerome, Anne Mithoefer, Mark Wagner, Zach Walsh, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson, Rick Doblin. Psychopharmacology (Berl) 2019
105
35

Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.
G J H Dumont, F C G J Sweep, R van der Steen, R Hermsen, A R T Donders, D J Touw, J M A van Gerven, J K Buitelaar, R J Verkes. Soc Neurosci 2009
141
32

MDMA enhances emotional empathy and prosocial behavior.
Cédric M Hysek, Yasmin Schmid, Linda D Simmler, Gregor Domes, Markus Heinrichs, Christoph Eisenegger, Katrin H Preller, Boris B Quednow, Matthias E Liechti. Soc Cogn Affect Neurosci 2014
149
30

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.
Roland R Griffiths, Matthew W Johnson, Michael A Carducci, Annie Umbricht, William A Richards, Brian D Richards, Mary P Cosimano, Margaret A Klinedinst. J Psychopharmacol 2016
556
30

Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA.
Michael C Mithoefer, Charles S Grob, Timothy D Brewerton. Lancet Psychiatry 2016
118
27

The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level-Dependent Resting State Functional Connectivity.
Robin L Carhart-Harris, Kevin Murphy, Robert Leech, David Erritzoe, Matthew B Wall, Bart Ferguson, Luke T J Williams, Leor Roseman, Stefan Brugger, Ineke De Meer,[...]. Biol Psychiatry 2015
71
27

The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?
Anya K Bershad, Melissa A Miller, Matthew J Baggott, Harriet de Wit. J Psychopharmacol 2016
49
25

A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy").
M R Thompson, P D Callaghan, G E Hunt, J L Cornish, I S McGregor. Neuroscience 2007
164
25

Effects of acute MDMA intoxication on mood and impulsivity: role of the 5-HT2 and 5-HT1 receptors.
Janelle H P van Wel, Kim P C Kuypers, Eef L Theunissen, Wendy M Bosker, Katja Bakker, Johannes G Ramaekers. PLoS One 2012
59
25

Separating the agony from ecstasy: R(-)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice.
Daniel W Curry, Matthew B Young, Andrew N Tran, Georges E Daoud, Leonard L Howell. Neuropharmacology 2018
20
50

Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.
Debra S Harris, Matthew Baggott, Jack H Mendelson, John E Mendelson, Reese T Jones. Psychopharmacology (Berl) 2002
147
25

Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study.
Alicia L Danforth, Charles S Grob, Christopher Struble, Allison A Feduccia, Nick Walker, Lisa Jerome, Berra Yazar-Klosinski, Amy Emerson. Psychopharmacology (Berl) 2018
64
25

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.
Stephen Ross, Anthony Bossis, Jeffrey Guss, Gabrielle Agin-Liebes, Tara Malone, Barry Cohen, Sarah E Mennenga, Alexander Belser, Krystallia Kalliontzi, James Babb,[...]. J Psychopharmacol 2016
460
25

Subjective reports of the effects of MDMA in a clinical setting.
G Greer, R Tolbert. J Psychoactive Drugs 1986
259
22

Effects of MDMA on sociability and neural response to social threat and social reward.
Gillinder Bedi, K Luan Phan, Mike Angstadt, Harriet de Wit. Psychopharmacology (Berl) 2009
109
22

MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults.
Alicia L Danforth, Christopher M Struble, Berra Yazar-Klosinski, Charles S Grob. Prog Neuropsychopharmacol Biol Psychiatry 2016
47
22

Differential effects of MDMA and methylphenidate on social cognition.
Yasmin Schmid, Cédric M Hysek, Linda D Simmler, Molly J Crockett, Boris B Quednow, Matthias E Liechti. J Psychopharmacol 2014
87
22

Multifaceted empathy of healthy volunteers after single doses of MDMA: A pooled sample of placebo-controlled studies.
Kim P C Kuypers, Patrick C Dolder, Johannes G Ramaekers, Matthias E Liechti. J Psychopharmacol 2017
48
22

The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories.
R L Carhart-Harris, M B Wall, D Erritzoe, M Kaelen, B Ferguson, I De Meer, M Tanner, M Bloomfield, T M Williams, M Bolstridge,[...]. Int J Neuropsychopharmacol 2014
47
22

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
Jennifer M Mitchell, Michael Bogenschutz, Alia Lilienstein, Charlotte Harrison, Sarah Kleiman, Kelly Parker-Guilbert, Marcela Ot'alora G, Wael Garas, Casey Paleos, Ingmar Gorman,[...]. Nat Med 2021
112
22

Safety pharmacology of acute MDMA administration in healthy subjects.
Patrick Vizeli, Matthias E Liechti. J Psychopharmacol 2017
67
20

3,4-Methylenedioxymethamphetamine Increases Affiliative Behaviors in Squirrel Monkeys in a Serotonin 2A Receptor-Dependent Manner.
Elizabeth G Pitts, Adelaide R Minerva, Erika B Chandler, Jordan N Kohn, Meghan T Logun, Agnieszka Sulima, Kenner C Rice, Leonard L Howell. Neuropsychopharmacology 2017
13
61



Progress and promise for the MDMA drug development program.
Allison A Feduccia, Julie Holland, Michael C Mithoefer. Psychopharmacology (Berl) 2018
28
28

Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning.
Briony J Catlow, Shijie Song, Daniel A Paredes, Cheryl L Kirstein, Juan Sanchez-Ramos. Exp Brain Res 2013
105
20

Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.
Michael P Bogenschutz, Alyssa A Forcehimes, Jessica A Pommy, Claire E Wilcox, P C R Barbosa, Rick J Strassman. J Psychopharmacol 2015
383
20

3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.
Marcela Ot'alora G, Jim Grigsby, Bruce Poulter, Joseph W Van Derveer, Sara Gael Giron, Lisa Jerome, Allison A Feduccia, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson,[...]. J Psychopharmacol 2018
60
20

3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats.
Holly S Hake, Jazmyne K P Davis, River R Wood, Margaret K Tanner, Esteban C Loetz, Anais Sanchez, Mykola Ostrovskyy, Erik B Oleson, Jim Grigsby, Rick Doblin,[...]. Physiol Behav 2019
14
57



Endocrine and neurochemical effects of 3,4-methylenedioxymethamphetamine and its stereoisomers in rhesus monkeys.
K S Murnane, W E Fantegrossi, J R Godfrey, M L Banks, L L Howell. J Pharmacol Exp Ther 2010
32
21




Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects.
Patrick C Dolder, Felix Müller, Yasmin Schmid, Stefan J Borgwardt, Matthias E Liechti. Psychopharmacology (Berl) 2018
57
17

Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy.
Mark T Wagner, Michael C Mithoefer, Ann T Mithoefer, Rebecca K MacAulay, Lisa Jerome, Berra Yazar-Klosinski, Rick Doblin. J Psychopharmacol 2017
44
17

Psychedelics Promote Structural and Functional Neural Plasticity.
Calvin Ly, Alexandra C Greb, Lindsay P Cameron, Jonathan M Wong, Eden V Barragan, Paige C Wilson, Kyle F Burbach, Sina Soltanzadeh Zarandi, Alexander Sood, Michael R Paddy,[...]. Cell Rep 2018
265
17

Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression.
Lindsay P Cameron, Charlie J Benson, Lee E Dunlap, David E Olson. ACS Chem Neurosci 2018
58
17

Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.
Charles S Grob, Alicia L Danforth, Gurpreet S Chopra, Marycie Hagerty, Charles R McKay, Adam L Halberstadt, George R Greer. Arch Gen Psychiatry 2011
439
17

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
A Richard Green, Annis O Mechan, J Martin Elliott, Esther O'Shea, M Isabel Colado. Pharmacol Rev 2003
816
15


Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study.
Cédric M Hysek, Linda D Simmler, Valentina G Nicola, Nerina Vischer, Massimiliano Donzelli, Stephan Krähenbühl, Eric Grouzmann, Jörg Huwyler, Marius C Hoener, Matthias E Liechti. PLoS One 2012
115
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.